Podcasts

Osilodrostat and Treatment of Cushing's Disease

November 02, 2020

Georgiana Dobri, MD, a neuroendocrinologist from Weill Cornell Medicine, discusses the approval of osilodrostat and management of Cushing's disease in 2020.

Addressing Racial Disparities in the Care of Children with Diabetes

October 30, 2020

A podcast episode featuring a discussion related to racial and ethnic disparities in the care of children with type 1 diabetes.

Raymond Douglas, MD, PhD: Treatment of Thyroid Eye Disease in 2020

October 19, 2020

Raymond Douglas, MD, PhD, discusses trends in treatment of thyroid eye disease and how the approval of teprotumumab has impacted the prospect of treating the condition.

The Endocrine Outlook: Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists

October 09, 2020

This episode of the Endocrine Outlook podcast features a discussion around the cardiorenal benefits of SGLT2 inhibitors and GLP-1 receptor agonists.

Prof. Heerspink: DAPA-CKD and Use of Dapagliflozin

September 03, 2020

A podcast featuring the presenter of DAPA-CKD discussing results of the trial and how they inform use of dapagliflozin in patients with chronic kidney disease with and without type 2 diabetes.

Joshua Denson, MD: Impact of Metabolic Syndrome in COVID-19 Patients

September 02, 2020

A podcast featuring the lead investigator of a recent study examining impact of metabolic syndrome on COVID-19 outcomes in a pair of New Orleans-based hospitals.

The Impact of COVID-19 on Diabetes Research

August 05, 2020

A medical researcher from the UK discusses how the ongoing pandemic has impacted diabetes research and how researchers have had to adapt during an uncertain time.

Robert Busch, MD: Reaction to EMPEROR-REDUCED Topline Results

August 01, 2020

An endocrinologist offers perspective on his reaction to EMPEROR-REDUCED topline results and what he hopes to see from the full results at ESC 2020.